Browsing by Author Bo, QY

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 4 of 4
TitleAuthor(s)Issue DateViews
 
Hepatitis B virus antigen reduction effect of RO7049389 plus NUC with/without Peg-IFN in chronic hepatitis B patients. Poster Presentation (THU408)
Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology
Hou, JLGane, EJZhang, WHZhang, JMYuen, RMFLim, THBalabanska, RXie, QKomolmit, PLiang, XZhang, WZhou, XXue, ZHTriyatni, MChen, EZhang, YCBo, QY
2022
 
RO7049389, a core protein allosteric modulator, demonstrates robust decline in HBV DNA and HBV RNA in chronic HBV infected patients
Proceeding/Conference:Journal of Hepatology
Gane, EYuen, RMFBo, QYSchwabe, .CTanwandee, TDas, SJin, YYGuo, LZhou, XWang, YFFeng, SMeinel, DZhu, MF
2019
37
 
Safety, pharmacokinetics, and antiviral activity of RO7049389, a core protein allosteric modulator, in patients with chronic hepatitis B virus infection: a multicentre, randomised, placebo-controlled, phase 1 trial
Journal:The Lancet Gastroenterology & Hepatology
Yuen, RMFZhou, XGane, ESchwabe, CTanwandee, TFeng, SJin, YYTriyatni, MLemenuel-Diot, ACosson, VXue, ZHKazma, RBo, QY
2021
 
The pharmacokinetic and safety profiles of RO7445482 SIRNA are similar between Asian and nonAsian healthy volunteers and chronic hepatitis B patients in a phase 1 Study
Proceeding/Conference:Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology
Gane, EJGuerreiro, NBuatois, SKim, WYoon, J-HLim, THSiever, WThompson, ASukeepaisarnjaroen, WTangkijvanich, PSchwabe, CBrown, BDTriyatni, MBo, QYAchneck, HYuen, RMF
2021
Showing results 1 to 4 of 4